Medication Guide App

MEDEVA SEMPREX-D (Semprex-D 8 mg-60 mg)

Generic Name: acrivastine/pseudoephedrine

Pill imprint MEDEVA SEMPREX-D has been identified as Semprex-D 8 mg-60 mg.

Semprex-D is used in the treatment of nasal congestion; hay fever and belongs to the drug class upper respiratory combinations. There is no proven risk in humans during pregnancy. Semprex-D 8 mg-60 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for MEDEVA SEMPREX-D (Semprex-D 8 mg-60 mg)

Semprex-D 8 mg-60 mg MEDEVA SEMPREX-D
Semprex-D
Generic Name:
acrivastine/pseudoephedrine
Imprint:
MEDEVA
SEMPREX-D
Strength:
8 mg-60 mg
Color:
Green & White
Availability:
Prescription only
Drug Class:
Upper respiratory combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Celltech Pharmaceuticals Inc.
National Drug Code (NDC):
53014-0404
Inactive Ingredients:
lactose
magnesium stearate
sodium starch glycolate
gelatin
D&C Yellow No. 10
FD&C Green No. 3
titanium dioxide

View Details Print Page

More about Semprex-D (acrivastine / pseudoephedrine)

Consumer resources

Professional resources

Compare with other treatments for:

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web3)